The Pension Fund Regulatory and Development Authority has published 40 vacancies for the recruitment of Officer Grade ‘A’ ...

A new leak has revealed the character banner lineup for Genshin Impact 6.0, including characters who will rerun alongside the ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Hemispherian's GLIX1 gains FDA approval for glioblastoma trials, promising a novel therapy targeting DNA repair in tumor ...

Safety Review Committee endorses escalation to 160 mg TUS dosingCohorts with 120 mg, 80 mg, 40 mg TUS dosing completed with ...

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced on Tuesday that its subsidiary Huge Biopharma Australia has received the ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

The Phase 1 clinical trials program increases patients’ access to novel research by bringing it closer to their homes. Distance should never stand between you and the latest medical breakthroughs. As ...

Previous reviews of phase 1 oncology trials reported a rate of response to treatment of 4 to 6 percent and a toxicity-related death rate of 0.5 percent. These results may not reflect the rates in c ...